TransMedics Group Inc

General ticker "TMDX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $2.4B

TransMedics Group Inc follows the US Stock Market performance with the rate: 26.1%.

Estimated limits based on current volatility of 1.9%: low 61.09$, high 63.42$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [57.87$, 112.29$]
  • 2024-12-30 to 2025-12-30 estimated range: [51.67$, 102.99$]

Financial Metrics affecting the TMDX estimates:

  • Negative: Non-GAAP EPS, $ of -0.11 <= 0.10
  • Negative: negative Net income
  • Negative: Operating profit margin, % of -10.63 <= 1.03
  • Negative: Operating cash flow per share per price, % of -0.53 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85

Similar symbols

Short-term TMDX quotes

Long-term TMDX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $30.26MM $93.46MM $241.62MM
Operating Expenses $69.69MM $124.90MM $270.35MM
Operating Income $-39.43MM $-31.44MM $-28.73MM
Non-Operating Income $-4.75MM $-4.73MM $2.06MM
Interest Expense $3.87MM $3.73MM $10.79MM
R&D Expense $22.30MM $26.81MM $36.05MM
Income(Loss) $-44.18MM $-36.16MM $-26.67MM
Taxes $0.04MM $0.07MM $-1.64MM
Profit(Loss) $-44.22MM $-36.23MM $-25.03MM
Stockholders Equity $67.85MM $187.38MM $137.20MM
Inventory $14.86MM $20.61MM $44.23MM
Assets $134.89MM $277.15MM $706.05MM
Operating Cash Flow $-28.86MM $-45.82MM $-13.03MM
Capital expenditure $3.52MM $11.91MM $179.06MM
Investing Cash Flow $29.27MM $54.51MM $-193.95MM
Financing Cash Flow $1.39MM $167.93MM $400.42MM
Earnings Per Share* $-1.60 $-1.23 $-0.77

* EPS are Split Adjusted, recent splits may be reflected with a delay.